期刊
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA
卷 28, 期 3, 页码 465-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.soc.2019.02.012
关键词
Adoptive T-cell transfer; Tumor-infiltrating lymphocytes; Neoantigens; Gene engineered T-cell receptor; Chimeric antigen receptor T cell
资金
- NATIONAL CANCER INSTITUTE [ZIABC011337] Funding Source: NIH RePORTER
The use of immunotherapies for solid and hematologic malignancies has demonstrated durable antitumor effects. Use of checkpoint inhibitors allows for immunologic reactivation of the adaptive immune system against tumor-specific neoantigens and effective rejection. Recent developments in adoptive transfer of T cells has shown effective immune rejection of solid malignancies and durable regression. Adoptive cell transfer involves extraction of in vivo T lymphocytes, selection for or introduction of tumor reactive cells, in vitro expansion, and delivery of the T-cell product back to the patient. This article discusses the different approaches, challenges, and further directions of adoptive T -cell transfer in solid malignancies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据